Eva Lonn
Impact in
-
- Blood Pressure and Hypertension Studies
- Cardiovascular Health and Disease Prevention
- Antiplatelet Therapy and Cardiovascular Diseases
-
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Blood Pressure and Hypertension Studies 46
- Cardiovascular Health and Disease Prevention 25
- Heart Failure Treatment and Management 23
- Cardiovascular Function and Risk Factors 11
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 12
- Co-authors
- Salim Yusuf (91 shared papers)Qilong Yi (20 shared papers)Hertzel C. Gerstein (22 shared papers)Koon Kang Teo (28 shared papers)Jackie Bosch (26 shared papers)Sonia Savitri Anand (12 shared papers)Monica Gianni (5 shared papers)Samer S. Najjar (1 shared paper)
- Journals
- Canadian Journal of Cardiology (26 papers)Circulation (14 papers)The Lancet (12 papers)Journal of the American College of Cardiology (12 papers)European Heart Journal (12 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Eva Lonn
244 papers receiving 27.9k citations
Eva Lonn's Hit Papers
Peers
Comparison fields: 5 of 171
- Cardiology and Cardiovascular Medicine 11.8k
- Endocrinology, Diabetes and Metabolism 4.8k
- Internal Medicine 849
- Surgery 6.8k
- Family Practice 262
Countries citing papers authored by Eva Lonn
This map shows the geographic impact of Eva Lonn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Lonn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Lonn more than expected).
Fields of papers citing papers by Eva Lonn
This network shows the impact of papers produced by Eva Lonn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Lonn. The network helps show where Eva Lonn may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Lonn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 250 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force Endorsed by the Society for Vascular Medicine Hit paper breakdown → | 2008 | 1963 |
| 2 | Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease Hit paper breakdown → | 2017 | 1765 |
| 3 | Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2018 | 1430 |
| 4 | Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review Hit paper breakdown → | 2006 | 1185 |
| 5 | 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult Hit paper breakdown → | 2016 | 974 |
| 6 | Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) Hit paper breakdown → | 2000 | 915 |
| 7 | Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence Hit paper breakdown → | 1999 | 759 |
| 8 | Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease Hit paper breakdown → | 2016 | 683 |
| 9 | Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2017 | 671 |
| 10 | Common Carotid Intima-Media Thickness Measurements in Cardiovascular Risk Prediction Hit paper breakdown → | 2012 | 632 |
| 11 | 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults Hit paper breakdown → | 2021 | 627 |
| 12 | 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations Hit paper breakdown → | 2009 | 623 |
| 13 | 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult Hit paper breakdown → | 2013 | 620 |
| 14 | Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2017 | 607 |
| 15 | Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials Hit paper breakdown → | 2019 | 604 |
| 16 | Effects of Ramipril and Vitamin E on Atherosclerosis Hit paper breakdown → | 2001 | 582 |
| 17 | Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease Hit paper breakdown → | 2016 | 470 |
| 18 | 2001 | 460 | |
| 19 | 1994 | 409 | |
| 20 | 2010 | 398 |
About Eva Lonn
Eva Lonn is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery, Biochemistry and Rheumatology, having authored 250 papers that have together received 29.4k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (46 papers), Lipoproteins and Cardiovascular Health (31 papers), Cardiovascular Health and Disease Prevention (25 papers), Heart Failure Treatment and Management (23 papers), Folate and B Vitamins Research (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers), Cardiovascular Function and Risk Factors (11 papers) and Health Systems, Economic Evaluations, Quality of Life (11 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (11.8k citations), Endocrinology, Diabetes and Metabolism (4.8k citations), Internal Medicine (849 citations), Surgery (6.8k citations) and Family Practice (262 citations). Eva Lonn has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Salim Yusuf, Qilong Yi, Hertzel C. Gerstein, Koon Kang Teo, Jackie Bosch, Sonia Savitri Anand, Monica Gianni, Samer S. Najjar, Wendy S. Post and James H. Stein. Their work appears in journals such as Canadian Journal of Cardiology, Circulation, The Lancet, Journal of the American College of Cardiology and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.